Manufacturer:
GSK
Route of Administration:
Oral
Site of Care:
Outpatient
Website:
Enrollment Forms:
Synergen Prescription Form
Approved Indication:
- prevention of Pneumocystis jirovecii pneumonia (PCP) in adults and adolescents aged 13 years and older who cannot tolerate trimethoprim-sulfamethoxazole (TMP-SMX)
- treatment of mild-to-moderate PCP in adults and adolescents aged 13 years and older who cannot tolerate TMP-SMX
Conditions:
- Pneumocystis
- jirovecii
- pneumonia
Therapeutic Area:
- Infectious Disease